View Older Stories

Jul 8, 2026 07:22AM Ligand Pharma (LGND) PT Raised to $332 at Stifel as Xoma Asset Acquisition Announced

May 7, 2026 07:42AM Ligand Pharma (LGND) Misses Q1 EPS by 21c

May 4, 2026 08:17AM Oppenheimer Assumes Ligand Pharma (LGND) at Outperform

Apr 28, 2026 11:03AM Ligand Pharma (LGND) PT Raised to $330 at Craig-Hallum

Apr 28, 2026 05:06AM Ligand Pharma (LGND) PT Raised to $252 at RBC Capital

Apr 27, 2026 02:55PM Ligand Pharma (LGND) PT Raised to $260 at BofA Securities

Apr 27, 2026 01:56PM Ligand Pharma (LGND) PT Raised to $255 at Stifel

Apr 27, 2026 06:17AM Ligand Pharma (LGND) to buy Xoma for ~$740M - WSJ

Apr 14, 2026 12:51PM Ligand Pharma (LGND) PT Raised to $282 at Citi

Apr 14, 2026 10:37AM Ligand Pharma (LGND) PT Raised to $243 at H.C. Wainwright

Apr 14, 2026 09:11AM Ligand Pharma (LGND) PT Raised to $250 at BofA Securities

Mar 24, 2026 05:03AM Citi Adjusts Catalyst Call List

Mar 11, 2026 06:03AM BofA Securities Starts Ligand Pharma (LGND) at Buy

Feb 27, 2026 06:06AM Ligand Pharma (LGND) PT Raised to $277 at Oppenheimer

Feb 26, 2026 02:59PM Stifel on Ligand Pharma (LGND): 'positioned for continued traction owing to MRK’s new ownership of Ohtuvayre'

Feb 26, 2026 07:11AM Ligand Pharma (LGND) Tops Q4 EPS by 53c ; Offers Guidance

Dec 10, 2025 08:46AM Benchmark Reiterates Buy Rating on Ligand Pharma (LGND) Following Strong Forecasts for 2025/26

Dec 10, 2025 06:54AM Oppenheimer Reiterates Outperform Rating on Ligand Pharma (LGND)

Dec 9, 2025 04:23PM Ligand Pharma (LGND) PT Raised to $230 at Stifel

Dec 9, 2025 05:03AM Citi Starts Ligand Pharma (LGND) at Buy

Nov 25, 2025 07:40AM RBC Capital Reiterates Outperform Rating on Ligand Pharma (LGND), Investor Day Preview

Nov 10, 2025 07:46AM Ligand Pharma (LGND) PT Raised to $234 at RBC Capital

Nov 7, 2025 08:01AM Pelthos Therapeutics acquires Xepi cream and raises $18 million

Nov 6, 2025 03:07PM Ligand Pharma (LGND) PT Raised to $220 at Stifel

Nov 6, 2025 07:21AM Ligand Pharma (LGND) Tops Q3 EPS by 116c ; Offers Guidance

Sep 3, 2025 06:50AM Ligand Pharma (LGND) PT Raised to $190 at Oppenheimer

Sep 2, 2025 07:37AM Ligand Pharma (LGND) PT Raised to $175 at Benchmark

Aug 29, 2025 06:53AM Ligand Pharma (LGND) PT Raised to $206 at H.C. Wainwright

Aug 8, 2025 02:10PM Ligand Pharma (LGND) PT Raised to $160 at Benchmark On Model Adjustment

Aug 8, 2025 08:49AM Ligand Pharma (LGND) PT Raised to $185 at RBC Capital

Aug 7, 2025 02:35PM Ligand Pharma (LGND) PT Raised to $167 at Oppenheimer

Aug 7, 2025 07:12AM Ligand Pharma (LGND) Tops Q2 EPS by 17c ; Offers Guidance

Aug 5, 2025 07:02AM Orchestra BioMed raises $111 million through equity offerings and partnerships

Jul 31, 2025 04:01PM Ligand and Medtronic invest $70 million in Orchestra BioMed

Jul 30, 2025 06:32AM Ligand Pharma (LGND) PT Raised to $162 at Oppenheimer

Jul 17, 2025 07:34AM Stifel Reiterates Buy Rating on Ligand Pharma (LGND)

Jul 10, 2025 08:02AM Ligand earns $5 million milestone as partner launches molluscum drug

Jul 9, 2025 08:28AM Stifel: 'MRK Acquisition of VRNA Should Broaden Opportunity for Ohtuvayre – A Core LGND Growth Driver'

Jul 2, 2025 07:01AM Ligand Pharma (LGND) Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics

May 8, 2025 07:14AM Ligand Pharma (LGND) Tops Q1 EPS by 11c ; Offers Guidance

Apr 9, 2025 04:06PM Stifel Starts Ligand Pharma (LGND) at Buy

Feb 28, 2025 09:31AM Ligand Pharma (LGND) PT Raised to $153 at RBC Capital Following a 'Strong Quarter'

Feb 27, 2025 07:12AM Ligand Pharma (LGND) Tops Q4 EPS by 9c ; Offers Guidance

Feb 25, 2025 07:27AM Ligand Pharma (LGND) Leads $75 Million Royalty Financing in Castle Creek Biosciences

Dec 23, 2024 10:18AM Benchmark on Ligand Pharma (LGND): '2025 Expected to Follow 2024 with Strong Revenue Growth'

Dec 11, 2024 07:55AM Ligand Pharma (LGND) PT Raised to $143 at RBC Capital

Dec 11, 2024 07:19AM Ligand Pharma (LGND) PT Raised to $150 at Oppenheimer

Dec 10, 2024 09:15AM Ligand Pharma (LGND) Introduces 2025 Guidance

Dec 3, 2024 08:09AM Ligand Pharma (LGND) PT Raised to $141 at RBC Capital Ahead of Investor Day

Nov 7, 2024 07:17AM Ligand Pharma (LGND) Tops Q3 EPS by 50c ; Offers Guidance

View Older Stories